Annexon (ANNX) Profit After Tax (2019 - 2026)
Annexon's (ANNX) quarterly Profit After Tax came in at -$44.1 million in Q1 2026, up 18.94% year-on-year from -$37.1 million in Q1 2025, and up 8.44% quarter-over-quarter from -$48.2 million in Q4 2025.
Annexon (ANNX) Profit After Tax (2019 - 2026) Analysis & Trends
Annexon's Profit After Tax history runs 8 years deep, the most recent figure standing at -$44.1 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 18.94% year-over-year to -$44.1 million in Q1 2026; TTM through Mar 2026 was -$196.4 million, a 17.28% decrease from a year earlier, with the FY2025 full-year figure at -$206.7 million, down 49.59% from the prior year.
- Profit After Tax rose to -$44.1 million in Q1 2026 per ANNX's latest filing, from -$48.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$25.2 million in Q1 2024 and bottomed at -$54.9 million in Q3 2025.
- The 5-year median for Profit After Tax is -$35.4 million (2022), against an average of -$39.1 million.
- Across the five-year window, Profit After Tax surged 34.91% in 2024 and slumped 116.31% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$34.2 million in 2022, then grew by 18.34% to -$27.9 million in 2023, then plunged by 74.21% to -$48.6 million in 2024, then increased by 0.78% to -$48.2 million in 2025, then grew by 8.44% to -$44.1 million in 2026.
- Per Business Quant, the three latest ANNX Profit After Tax figures stand at -$44.1 million (Q1 2026), -$48.2 million (Q4 2025), and -$54.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | -44.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.14 Mn |
| Dec 31, 2025 | -48.21 Mn |
| Sep 30, 2025 | -54.92 Mn |
| Jun 30, 2025 | -49.16 Mn |
| Mar 31, 2025 | -54.46 Mn |
| Dec 31, 2024 | -48.59 Mn |
| Sep 30, 2024 | -34.82 Mn |
| Jun 30, 2024 | -29.61 Mn |
| Mar 31, 2024 | -25.18 Mn |
| Dec 31, 2023 | -27.89 Mn |
| Sep 30, 2023 | -32.48 Mn |
| Jun 30, 2023 | -35.19 Mn |
| Mar 31, 2023 | -38.68 Mn |
| Dec 31, 2022 | -34.16 Mn |
| Sep 30, 2022 | -35.05 Mn |
| Jun 30, 2022 | -37.14 Mn |
| Mar 31, 2022 | -35.37 Mn |
| Dec 31, 2021 | -37.47 Mn |
| Sep 30, 2021 | -35.61 Mn |
| Jun 30, 2021 | -31.29 Mn |